Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Sitko

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Ophthalmology|July 25, 2016
ReplyKevin Sitko, Jason H Peragallo, Nancy J Newman, et al.
Molecular Endocrinology (Baltimore, Md.)|October 1, 2005
Insulin-like growth factor-I signaling in smooth muscle cells is regulated by ligand binding to the 177CYDMKTTC184 sequence of the beta3-subunit of alphaVbeta3Laura A Maile, Walker H Busby, Kevin Sitko, et al.
Molecular Endocrinology (Baltimore, Md.)|December 3, 2005
The heparin binding domain of vitronectin is the region that is required to enhance insulin-like growth factor-I signalingLaura A Maile, Walker H Busby, Kevin Sitko, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Ophthalmology|July 25, 2016
ReplyKevin Sitko, Jason H Peragallo, Nancy J Newman, et al.
Molecular Endocrinology (Baltimore, Md.)|October 1, 2005
Insulin-like growth factor-I signaling in smooth muscle cells is regulated by ligand binding to the 177CYDMKTTC184 sequence of the beta3-subunit of alphaVbeta3Laura A Maile, Walker H Busby, Kevin Sitko, et al.
Molecular Endocrinology (Baltimore, Md.)|December 3, 2005
The heparin binding domain of vitronectin is the region that is required to enhance insulin-like growth factor-I signalingLaura A Maile, Walker H Busby, Kevin Sitko, et al.
Pageof 1